Clinical Trial Update: Cell Therapy in Chronic Ischemic Heart Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a cell therapy for ischemic heart disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Cell Therapy

Snippet

Sponsor: Ministry of Health, Brazil | Conditions: Ischemic Heart Disease, Coronary Artery Disease | Phase 3 | Status: TERMINATED